- Home
- NVVE vs ADIL Comparison
NVVE vs ADIL Comparison
Compare NVVE & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- ADIL
- Stock Information
- Founded
- NVVE 1996
- ADIL 2010
- Country
- NVVE United States
- ADIL United States
- Employees
- NVVE N/A
- ADIL N/A
- Industry
- NVVE Oil Refining/Marketing
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- NVVE Energy
- ADIL Health Care
- Exchange
- NVVE Nasdaq
- ADIL Nasdaq
- Market Cap
- NVVE 3.7M
- ADIL 4.3M
- IPO Year
- NVVE N/A
- ADIL 2018
- Fundamental
- Price
- NVVE $0.91
- ADIL $0.72
- Analyst Decision
- NVVE
- ADIL Strong Buy
- Analyst Count
- NVVE 0
- ADIL 1
- Target Price
- NVVE N/A
- ADIL $8.00
- AVG Volume (30 Days)
- NVVE 113.1K
- ADIL 50.4K
- Earning Date
- NVVE 05-13-2025
- ADIL 05-13-2025
- Dividend Yield
- NVVE N/A
- ADIL N/A
- EPS Growth
- NVVE N/A
- ADIL N/A
- EPS
- NVVE N/A
- ADIL N/A
- Revenue
- NVVE $5,286,229.00
- ADIL N/A
- Revenue This Year
- NVVE $892.33
- ADIL N/A
- Revenue Next Year
- NVVE N/A
- ADIL N/A
- P/E Ratio
- NVVE N/A
- ADIL N/A
- Revenue Growth
- NVVE N/A
- ADIL N/A
- 52 Week Low
- NVVE $0.82
- ADIL $0.58
- 52 Week High
- NVVE $17.30
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- NVVE 30.90
- ADIL 50.77
- Support Level
- NVVE $0.87
- ADIL $0.65
- Resistance Level
- NVVE $0.99
- ADIL $0.74
- Average True Range (ATR)
- NVVE 0.09
- ADIL 0.07
- MACD
- NVVE 0.03
- ADIL 0.00
- Stochastic Oscillator
- NVVE 31.03
- ADIL 61.36
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.